(Q54410118)

29 May 2018

title

Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma. (English)

1 reference

29 May 2018

1 reference

10

1 reference

29 May 2018

Lan Kluwe

4

object named as

Lan Kluwe

1 reference

29 May 2018

Ralf Smeets

7

object named as

Ralf Smeets

1 reference

29 May 2018

author name string

Alexander Gröbe

1

1 reference

29 May 2018

Wolfgang Eichhorn

2

1 reference

29 May 2018

Meike Fraederich

3

1 reference

29 May 2018

Yogesh Vashist

5

1 reference

29 May 2018

Johannes Wikner

6

1 reference

29 May 2018

Ronald Simon

8

1 reference

29 May 2018

Guido Sauter

9

1 reference

29 May 2018

Marco Blessmann

11

1 reference

29 May 2018

publication date

11 September 2013

1 reference

29 May 2018

Journal of Oral Pathology & Medicine

published in

1 reference

29 May 2018

volume

43

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

205-210

1 reference

29 May 2018

Minimal residual disease in head and neck cancer

cites work

1 reference

Metastasis of squamous cell carcinoma of the oral tongue

21 January 2018

1 reference

Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.

21 January 2018

1 reference

Role of HER2 in wound-induced breast carcinoma proliferation.

21 January 2018

1 reference

Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature

21 January 2018

1 reference

Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival.

21 January 2018

1 reference

Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?

21 January 2018

1 reference

Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma

21 January 2018

1 reference

Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis

21 January 2018

1 reference

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

21 January 2018

1 reference

Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy

21 January 2018

1 reference

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer

21 January 2018

1 reference

Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer

21 January 2018

1 reference

Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.

21 January 2018

1 reference

Epidermal growth factor receptor (EGFR) signaling in cancer

21 January 2018

1 reference

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

21 January 2018

1 reference

Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions.

21 January 2018

1 reference

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer

21 January 2018

1 reference

Prognostic Value of an Activation State Marker for Epidermal Growth Factor Receptor in Tissue Microarrays of Head and Neck Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JOP.12111

1 reference

29 May 2018

1 reference

29 May 2018